Najoua Gdl’s Post

View profile for Najoua Gdl

faculte des lettre langue et arts ibn tofail

AI is fundamentally dependent on data, but the vast majority of health data goes unused for understandable reasons — chiefly patient privacy, regulation and IP protection. “This is the core underlying problem” of building AI solutions for life sciences and related areas like pharmaceutics, said German entrepreneur Robin Röhm. And not only that: collaboration when […] © 2024 TechCrunch. All rights reserved. For personal use only.AI in healthcare relies heavily on data, yet a significant portion remains untapped due to privacy concerns, regulations, and intellectual property issues. German entrepreneur Robin Röhm emphasizes that these challenges are fundamental barriers to developing AI solutions in life sciences and pharmaceuticals. Additionally, collaboration among stakeholders is hindered, exacerbating the difficulties in leveraging health data effectively to drive innovation and improve patient outcomes.Apheris rethinks the AI data bottleneck in life science with federated computing

To view or add a comment, sign in

Explore topics